Aspire Biopharma Holdings (ASBP) Inventory (2025 - 2026)

Aspire Biopharma Holdings (ASBP) posted quarterly Inventory of $369974.0 for Q1 2026, up 46.14% quarter-over-quarter from $253160.0 in Q4 2025.

Aspire Biopharma Holdings (ASBP) Inventory (2025 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has reported Inventory for 2 consecutive years, with $369974.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Inventory changed N/A year-over-year to $369974.0; the TTM figure through Mar 2026 stood at $369974.0 (changed N/A YoY), while the FY2025 annual figure was $253160.0, changed N/A from the prior year.
Inventory climbed to $369974.0 in Q1 2026 per ASBP's latest filing, from $253160.0 in the prior quarter.
Across five years, Inventory topped out at $369974.0 in Q1 2026 and bottomed at $35437.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	3.08 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	371.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	280.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	732.60 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	97.11 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	128.86 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	142.38 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Aspire Biopharma Holdings	8.30 Mn	-3.86 Mn	-30,086.00	288,450.00

Download Data